Literature DB >> 12782654

Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2.

Xiao-Ding Peng1, Pei-Zhang Xu, Mei-Ling Chen, Annett Hahn-Windgassen, Jennifer Skeen, Joel Jacobs, Deepa Sundararajan, William S Chen, Susan E Crawford, Kevin G Coleman, Nissim Hay.   

Abstract

To elucidate the functions of the serine/threonine kinase Akt/PKB in vivo, we generated mice lacking both akt1 and akt2 genes. Akt1/Akt2 double-knockout (DKO) mice exhibit severe growth deficiency and die shortly after birth. These mice display impaired skin development because of a proliferation defect, severe skeletal muscle atrophy because of a marked decrease in individual muscle cell size, and impaired bone development. These defects are strikingly similar to the phenotypes of IGF-1 receptor-deficient mice and suggest that Akt may serve as the most critical downstream effector of the IGF-1 receptor during development. In addition, Akt1/Akt2 DKO mice display impeded adipogenesis. Specifically, Akt1 and Akt2 are required for the induced expression of PPARgamma, the master regulator of adipogenesis, establishing a new essential role for Akt in adipocyte differentiation. Overall, the combined deletion of Akt1 and Akt2 establishes in vivo roles for Akt in cell proliferation, growth, and differentiation. These functions of Akt were uncovered despite the observed lower level of Akt activity mediated by Akt3 in Akt1/Akt2 DKO cells, suggesting that a critical threshold level of Akt activity is required to maintain normal cell proliferation, growth, and differentiation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12782654      PMCID: PMC196068          DOI: 10.1101/gad.1089403

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  61 in total

1.  PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro.

Authors:  E D Rosen; P Sarraf; A E Troy; G Bradwin; K Moore; D S Milstone; B M Spiegelman; R M Mortensen
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

2.  PPAR gamma is required for placental, cardiac, and adipose tissue development.

Authors:  Y Barak; M C Nelson; E S Ong; Y Z Jones; P Ruiz-Lozano; K R Chien; A Koder; R M Evans
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

3.  Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells.

Authors:  L N Cong; H Chen; Y Li; L Zhou; M A McGibbon; S I Taylor; M J Quon
Journal:  Mol Endocrinol       Date:  1997-12

4.  Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

Authors:  C Rommel; S C Bodine; B A Clarke; R Rossman; L Nunez; T N Stitt; G D Yancopoulos; D J Glass
Journal:  Nat Cell Biol       Date:  2001-11       Impact factor: 28.824

5.  A human protein kinase Bgamma with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain.

Authors:  D Brodbeck; P Cron; B A Hemmings
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

Review 6.  Ribosomal S6 kinase signaling and the control of translation.

Authors:  A Dufner; G Thomas
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

Review 7.  The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB.

Authors:  E S Kandel; N Hay
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

8.  4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway.

Authors:  A C Gingras; S G Kennedy; M A O'Leary; N Sonenberg; N Hay
Journal:  Genes Dev       Date:  1998-02-15       Impact factor: 11.361

9.  Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha.

Authors:  K S Walker; M Deak; A Paterson; K Hudson; P Cohen; D R Alessi
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

10.  Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin.

Authors:  D A Altomare; G E Lyons; Y Mitsuuchi; J Q Cheng; J R Testa
Journal:  Oncogene       Date:  1998-05-07       Impact factor: 9.867

View more
  331 in total

1.  S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway.

Authors:  Mario Pende; Sung Hee Um; Virginie Mieulet; Melanie Sticker; Valerie L Goss; Jurgen Mestan; Matthias Mueller; Stefano Fumagalli; Sara C Kozma; George Thomas
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 2.  Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Authors:  Silvie Foldynova-Trantirkova; William R Wilcox; Pavel Krejci
Journal:  Hum Mutat       Date:  2011-11-16       Impact factor: 4.878

3.  O(2) regulates skeletal muscle progenitor differentiation through phosphatidylinositol 3-kinase/AKT signaling.

Authors:  Amar J Majmundar; Nicolas Skuli; Rickson C Mesquita; Meeri N Kim; Arjun G Yodh; Michelle Nguyen-McCarty; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

4.  Oxidation of Akt2 kinase promotes cell migration and regulates G1-S transition in the cell cycle.

Authors:  Revati Wani; N Sharmila Bharathi; Jeffrey Field; Allen W Tsang; Cristina M Furdui
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

5.  Circadian variations in gene expression in rat abdominal adipose tissue and relationship to physiology.

Authors:  Siddharth Sukumaran; Bai Xue; William J Jusko; Debra C Dubois; Richard R Almon
Journal:  Physiol Genomics       Date:  2010-08-03       Impact factor: 3.107

6.  Akt determines cell fate through inhibition of the PERK-eIF2α phosphorylation pathway.

Authors:  Zineb Mounir; Jothi Latha Krishnamoorthy; Shuo Wang; Barbara Papadopoulou; Shirley Campbell; William J Muller; Maria Hatzoglou; Antonis E Koromilas
Journal:  Sci Signal       Date:  2011-09-27       Impact factor: 8.192

7.  Short-term akt activation in cardiac muscle cells improves contractile function in failing hearts.

Authors:  Ichiro Shiojima; Stephan Schiekofer; Jochen G Schneider; Kurt Belisle; Kaori Sato; Martin Andrassy; Gennaro Galasso; Kenneth Walsh
Journal:  Am J Pathol       Date:  2012-09-30       Impact factor: 4.307

8.  FAK Promotes Early Osteoprogenitor Cell Proliferation by Enhancing mTORC1 Signaling.

Authors:  Shuqun Qi; Xiumei Sun; Han Kyoung Choi; Jinfeng Yao; Li Wang; Guomin Wu; Yun He; Jian Pan; Jun-Lin Guan; Fei Liu
Journal:  J Bone Miner Res       Date:  2020-06-05       Impact factor: 6.741

9.  Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy.

Authors:  Ka-Man V Lai; Michael Gonzalez; William T Poueymirou; William O Kline; Erqian Na; Elizabeth Zlotchenko; Trevor N Stitt; Aris N Economides; George D Yancopoulos; David J Glass
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells.

Authors:  Mohd Minhajuddin; Kaiser M Bijli; Fabeha Fazal; Antonella Sassano; Keiichi I Nakayama; Nissim Hay; Leonidas C Platanias; Arshad Rahman
Journal:  J Biol Chem       Date:  2008-12-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.